CompletedPhase 3NCT04410406
Moxidectin for LF, Cote d'Ivoire (DOLF)
Studying Filariasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Washington University School of Medicine
- Principal Investigator
- Philip Budge, MD, PhDWashington University School of Medicine
- Intervention
- Ivermectin(drug)
- Enrollment
- 164 enrolled
- Eligibility
- 18-70 years · All sexes
- Timeline
- 2020 – 2024
Study locations (1)
- Regional Hospital of Agboville, Southern Cote d'Ivoire, Agboville, Côte d’Ivoire
Collaborators
Case Western Reserve University · Centre Suisse de Recherches Scientifiques en Cote d'Ivoire
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04410406 on ClinicalTrials.govOther trials for Filariasis
Additional recruiting or active studies for the same condition.